5-HT 6 antagonists (Proximagen)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5-HT 6 antagonists (Proximagen)
Drug Alias Name5-HT 6 antagonists (Proximagen)5-HT 6 antagonists (Biovitrum)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 6 (5-HT6) receptor antagonists
TargetsSerotonin 6 (5-HT6) receptor
Therapy Area/IndicationsCognition DisordersPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSwedish Orphan Biovitrum Ab (Publ)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProximagen Group plc
Active IndicationsN/A
Inactive IndicationsCognition DisordersPain

Other Information

ATC CodeN/A
Related LinksN/A